IDH1 and acute myeloid leukemia: BAY1436032 is an inhibitor of pan IDH1 mutations and is highly effective against all known IDH1 mutations in both human-derived AML cells [139] and IDH1 R132H, R132C R132G, R132L, and R132S mutated cell lines [140].